Latest Capital Expenditure News

SomnoMed Limited reported a record FY25 with $111.5 million revenue and a return to positive EBITDA, marking a milestone of over one million patients treated globally. The company secured FDA clearance for its Rest Assure® compliance tracking device and provided optimistic guidance for FY26.

Lynas Rare Earths reported FY25 results featuring record NdPr output and the first commercial heavy rare earths production outside China, alongside a $750 million equity raise to fund its ambitious Towards 2030 growth strategy.

Lynas Rare Earths reports FY25 revenue growth amid profit decline, completes major capital projects, and launches a $750 million equity raise to fund its expansive Towards 2030 strategy.

Lynas Rare Earths reported a 20% revenue increase in FY25 driven by higher NdPr sales, yet net profit fell sharply amid ramp-up costs and market challenges. The company completed key growth projects and unveiled its Towards 2030 strategy focused on downstream expansion.

Ramsay Health Care reported a modest 1.7% increase in underlying net profit for FY25, driven by strong Australian and UK hospital performances despite significant impairments in the UK. The company is advancing its multi-year transformation and expects EBIT growth in Australia for FY26, though challenges remain.

Ramsay Health Care posted solid revenue growth driven by its Australian and UK hospital businesses, despite a significant impairment charge impacting net profit. The group advances a multi-year transformation focusing on operational efficiency and capital discipline.

Qantas Airways reported a robust 15% increase in underlying profit before tax for FY25, driven by strong operational performance and strategic fleet investments. The airline also announced a fully franked final dividend and special dividend, underscoring its financial strength and shareholder focus.

Ramsay Health Care reported a 6.8% revenue increase and a modest rise in underlying profit for FY25, despite a significant impairment in its UK mental health division. The company maintains a strong dividend and outlines a cautiously optimistic outlook for FY26.

South32 reported a robust turnaround in FY25 with a profit after tax of US$213 million and underlying earnings of US$666 million, driven by operational gains and strategic portfolio shifts. The company also advanced construction at its Hermosa project and maintained a strong balance sheet with net cash of US$123 million.

South32 Limited reported a robust turnaround in FY25 with a 17% revenue increase and a return to profitability, driven by higher commodity prices and strategic divestments. The company also declared a fully-franked dividend and outlined a focused growth outlook.

Qantas Airways posted a robust FY25 financial performance with a 28% rise in statutory profit after tax, supported by strong travel demand and strategic fleet investments. The Group also announced substantial dividends and completed a $431 million share buy-back, while closing Jetstar Asia to focus on core markets.

TPG Telecom reports solid half-year growth driven by 100,000 new mobile subscribers and strong cash flow, while unveiling a $3 billion capital return plan.